InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Gilbert Halley E, Directeur Juridique. Director active across 3 companies, notably Neogenomics INC. Aggregated, 15 filings have been logged. History available since 17 August 2021. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Gilbert Halley E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
2,265 股Common StockSEC:0001601360-26-000002:0
5,778 股0Common StockSEC:0001628280-26-042040:0
12,220 股@ US$7.51100.0% 占其流量Common StockSEC:0001601360-25-000007:0
7,609 股0Common StockSEC:0002065881-25-000023:0
3,041 股0Common StockSEC:0001601360-25-000003:0
10,139 股0Common StockSEC:0001787306-24-000100:0
1,550 股0Common StockSEC:0001649094-24-000013:0
18,200 股@ US$5.35100.0% 占其流量Common StockSEC:0001415889-24-015590:0
2,500 股0Common StockSEC:0001209191-23-037501:0
4,375 股0Common StockSEC:0001787306-23-000056:0
3,125 股0Common StockSEC:0001209191-22-034050:0
4,312 股0Common StockSEC:0001567619-22-012319:0
42,036 股0Common StockSEC:0001077183-22-000044:0
45,858 股0Common StockSEC:0001077183-21-000272:0
59,228 股0Common StockSEC:0001077183-21-000214:0
15 条申报中的 15 条
About Gilbert Halley E
Gilbert Halley E is Chief Legal Officer. He has 15 filings in total, and across the 15 most recent sampled filings, the modal transaction nature is Award, with a date range from 2021-08-19 to 2026-06-16. The companies mentioned in his filings include Vaxcyte, Inc., Arcutis Biotherapeutics, Inc. and Neogenomics INC, and the main amounts shown in the recent sample include EUR 89269.79003862172 and EUR 79520.60975956575.
